Sverre E Kjeldsen Selected Research

Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)

10/2020	On-treatment HDL cholesterol predicts incident atrial fibrillation in hypertensive patients with left ventricular hypertrophy.
1/2018	The relationship of all-cause mortality to average on-treatment systolic blood pressure is significantly related to baseline systolic blood pressure: implications for interpretation of the Systolic Blood Pressure Intervention Trial study.
10/2016	Impact of achieved systolic blood pressure on renal function in hypertensive patients.
1/2016	No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial.
1/2016	Electrocardiographic left atrial abnormalities and risk of incident stroke in hypertensive patients with electrocardiographic left ventricular hypertrophy.
8/2015	Effect of lower on-treatment systolic blood pressure on the risk of atrial fibrillation in hypertensive patients.
8/2015	Systolic Blood Pressure Control and Mortality After Stroke in Hypertensive Patients.
7/2015	Digoxin use and risk of mortality in hypertensive patients with atrial fibrillation.
7/2014	Racial differences in incident atrial fibrillation among hypertensive patients during antihypertensive therapy.
4/2014	Persistence of left ventricular hypertrophy is associated with increased cardiovascular morbidity and mortality in hypertensive patients with lower achieved systolic pressure during antihypertensive treatment.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sverre E Kjeldsen Research Topics

Disease

142	Hypertension (High Blood Pressure) 03/2022 - 03/2002
65	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 10/2020 - 03/2002
53	Stroke (Strokes) 10/2021 - 03/2002
41	Myocardial Infarction 01/2020 - 01/2002
30	Heart Failure 01/2021 - 06/2004
18	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 03/2002
17	Atrial Fibrillation 10/2020 - 03/2005
15	Diabetes Mellitus 01/2018 - 09/2002
11	Isolated Systolic Hypertension 10/2019 - 09/2002
11	Coronary Disease (Coronary Heart Disease) 08/2017 - 04/2003
9	Essential Hypertension 01/2019 - 01/2002
8	Type 2 Diabetes Mellitus (MODY) 01/2021 - 05/2005
8	Hypertrophy 03/2019 - 03/2005
7	Myocardial Ischemia (Ischemic Heart Diseases) 01/2019 - 01/2006
6	Albuminuria 10/2016 - 03/2002
5	Insulin Resistance 09/2015 - 01/2004
4	Neoplasms (Cancer) 01/2019 - 09/2010
4	Cardiac Sudden Death (Sudden Cardiac Arrest) 04/2012 - 03/2005
3	Bundle-Branch Block (Fascicular Block) 01/2019 - 06/2008
3	Proteinuria 01/2016 - 01/2008
3	Peripheral Vascular Diseases (Peripheral Vascular Disease) 07/2014 - 01/2006
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2009 - 10/2008
2	Peripheral Arterial Disease 01/2022 - 03/2011
2	Masked Hypertension 01/2019 - 06/2015
2	ST Elevation Myocardial Infarction 06/2011 - 07/2010
2	Infarction (Infarctions) 06/2011 - 01/2002
2	Hypercholesterolemia 08/2009 - 05/2005
1	Erectile Dysfunction 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	COVID-19 01/2021
1	Celiac Disease (Celiac Sprue) 01/2020
1	Left Ventricular Dysfunction 12/2016

Drug/Important Bio-Agent (IBA)

80	Losartan (Cozaar)FDA LinkGeneric 03/2022 - 03/2002
76	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 03/2002
68	Atenolol (Tenormin)FDA LinkGeneric 01/2018 - 01/2002
18	Angiotensin Receptor AntagonistsIBA 01/2021 - 11/2004
17	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2002
17	CreatinineIBA 01/2019 - 03/2002
16	DiureticsIBA 12/2020 - 01/2002
15	Valsartan (Vals)FDA Link 01/2021 - 06/2004
15	Pharmaceutical PreparationsIBA 12/2020 - 09/2002
13	Amlodipine (Norvasc)FDA LinkGeneric 01/2020 - 06/2004
13	AlbuminsIBA 12/2015 - 03/2002
12	HDL CholesterolIBA 10/2020 - 09/2005
9	CholesterolIBA 10/2021 - 04/2003
8	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2021 - 03/2005
8	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 09/2014 - 01/2005
6	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 11/2004
6	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 11/2014 - 04/2006
5	Neprilysin (Neutral Endopeptidase)IBA 01/2021 - 12/2012
5	CalciumIBA 12/2016 - 01/2002
5	LipidsIBA 03/2009 - 04/2003
4	candesartanIBA 01/2020 - 03/2011
4	Uric Acid (Urate)IBA 08/2010 - 01/2003
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2009 - 04/2003
3	paragonIBA 01/2020 - 01/2019
3	Telmisartan (Micardis)FDA Link 06/2018 - 04/2010
3	candesartan cilexetil (Amias)FDA Link 01/2016 - 01/2005
3	Triglycerides (Triacylglycerol)IBA 09/2015 - 07/2003
3	benazepril (Briem)FDA LinkGeneric 04/2012 - 06/2010
3	ThiazidesIBA 04/2012 - 09/2005
3	Hemoglobins (Hemoglobin)IBA 01/2009 - 01/2003
3	A 19IBA 12/2008 - 08/2007
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 05/2007 - 01/2002
3	Atorvastatin (Lipitor)FDA Link 05/2005 - 04/2003
3	Angiotensin IIIBA 01/2005 - 01/2003
2	Spironolactone (Aldactone)FDA LinkGeneric 01/2021 - 01/2020
2	Perindopril FDA LinkGeneric 01/2020 - 09/2005
2	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2020 - 01/2019
2	Nifedipine (Adalat)FDA LinkGeneric 01/2016 - 12/2014
2	Digoxin (Digitek)FDA LinkGeneric 07/2015 - 04/2013
2	Drug CombinationsIBA 02/2015 - 09/2005
2	pro-brain natriuretic peptide (1-76)IBA 06/2011 - 08/2006
2	Indicators and Reagents (Reagents)IBA 06/2011 - 03/2002
2	Brain Natriuretic Peptide (Natrecor)FDA Link 06/2011 - 08/2006
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2010 - 09/2005
2	HDL LipoproteinsIBA 06/2010 - 09/2009
2	Epinephrine (Adrenaline)FDA LinkGeneric 01/2008 - 07/2004
2	Carvedilol (Coreg)FDA LinkGeneric 01/2007 - 01/2002
2	Diltiazem (Cardizem)FDA LinkGeneric 06/2002 - 01/2002
1	beta Adrenergic ReceptorsIBA 01/2021
1	SodiumIBA 01/2021
1	finerenoneIBA 01/2021
1	Irbesartan FDA LinkGeneric 01/2020
1	Olmesartan Medoxomil (Votum)FDA Link 01/2020
1	Mineralocorticoid Receptor AntagonistsIBA 01/2020
1	Natriuretic PeptidesIBA 03/2019
1	Lisinopril (Prinivil)FDA LinkGeneric 01/2019
1	Chlorthalidone (Chlortalidone)FDA LinkGeneric 01/2019
1	Ramipril (Altace)FDA LinkGeneric 06/2018
1	Verapamil (Calan)FDA LinkGeneric 06/2018
1	trandolapril (Mavik)FDA LinkGeneric 06/2018
1	AS 35IBA 08/2017
1	salicylhydroxamic acid (SHAM)IBA 08/2017

Therapy/Procedure

66	Therapeutics 01/2022 - 04/2003
10	Denervation 12/2017 - 05/2012
9	Sympathectomy (Sympathectomies) 01/2019 - 05/2013
4	Drug Therapy (Chemotherapy) 01/2020 - 11/2005
2	Catheters 12/2017 - 05/2012
1	Electrodes (Electrode) 12/2017